Amneal Biosciences

RELUKO - Cost

Last Updated: April 1st, 2024

HCPCS:

Q5125

HCPCS Code Descriptor:

Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram

Medicare Payment Limit:

The RELUKO Medicare Payment Limit is $0.526

Average Sale Price:

RELUKO ASP cost available once logged in. Reluko is a biosimilar drug making the ASP calculation more complex. Reluko's ASP is based on the average sale price of its biosimilar reference drug.

Medicare Co-Insurance Percentage:

The RELUKO Medicare Co-insurance percentage is 20%. RELUKO's Medicare Co-insurance amount is $0.11 per HCPCS unit.

APC Code:

The Reluko APC Code is: 9447

APC Payment Limit:

The APC Payment Limit for RELUKO is available. Login to view.

Reluko Cost Information:

RELUKO, HCPCS Q5125, became effective on October 1, 2022. There are six NDCs mapped to Q5125 with a couple possible errors found. From its introduction, AWP and WAC have experienced no changes. Adversely, ASP has declined by just over 10%.

ACCESS PRICING AND MORE BY REGISTERING

Reluko’s wholesale acquisition cost (WAC) information was last updated on:
November 11, 2022
Reluko’s average wholesale price (AWP) information was last updated on:
November 11, 2022

Reluko Cost Graph: